Ramsdens Holdings (Aim: RFX), worth £83 million, provides financial services through four channels: foreign-currency exchange (forex); pawnbroking; jewellery and watch retail (new and second-hand); and precious-metal purchases. Pre-owned jewellery and watches sell at substantial prices, with diamond rings fetching between £100 and £40,000, and Rolex watches £2,000-£30,000.
The firm is well diversified, as these four channels all provide comparable profit contributions. In addition, Ramsdens offers money transfers through Western Union, which makes a small contribution to overall earnings.
Ramsdens Holdings' four-part growth strategy
Ramsdens serves its customers through an expanding estate of 169 UK stores and a growing online presence. Websites operate for jewellery and forex (with a click-and-collect service). A pawnbroking site opened in November 2024, and a gold-buying one came online in March 2025. Online sales now make up 20% of jewellery revenue and 12% of forex sales. These proportions are expected to increase.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company has a four-pronged growth strategy: driving growth from the existing store estate, adding new shops, acquisition opportunities, and growing its online presence. The three main UK pawnbroking companies – H&T, Cash Converters and Ramsdens – have about 650 stores between them, compared with about 130 competitors with a total of around 220 stores between them. As there are only one or two shops per business, there are opportunities for acquisition as the sector consolidates.
Beyond London, the UK has some 350 locations with populations over 30,000, so there are significant opportunities to expand Ramsdens’ current estate of 169 shops, particularly in areas south of a line between Bristol and The Wash, where it currently has only nine of its stores and is looking for opportunities to acquire more, in addition to seeking out suitable sites.
A new branch typically makes a loss in its first year, a small profit of around £30,000 in its second year and a profit of £100,000 in its fourth. Seven new shops were opened in 2023-2024, together with one purchased from a franchisee, leaving only one franchised store in the current 169. A further five new shops are set to open in 2024-2025.
The increasing profit as a store matures means that all shops opened in 2021-2022 or later will increase their profit in 2024-2025. Ramsdens has flexible store leases, and where appropriate, it relocates shops to areas of higher footfall and in which the site offers a larger window display. Three stores were relocated in 2023-2024 and are already showing improved performance.
Online expansion
Ramsdens’ online presence is growing and in the second half of 2023-2024 online sales grew 35% year on year to £4 million, or almost 8% of total revenue. Ramsdens has 15,000 items on its jewellery website and premium watches comprise 65% of jewellery sales. The pawnbroking website opened in late 2024 and the gold-buying website began trading in March 2025. Both should help to accelerate online sales.
Ramsdens has a strong balance sheet with cash of £15.8 million and debt of £8.4 million (as of 30 September 2024). Current lease liabilities are £2.4 million, with non-current ones worth £7.3 million. This healthy balance sheet gives the company the financial strength to make acquisitions or invest in new shops.
In addition, the company has a £15 million revolving credit facility to provide working capital for growth and to fund people’s summer currency requirements. On 30 September 2024, £8.5 million had been drawn from it. Net operating cash flow in 2023- 2024 was sufficient to cover generous dividends and add to the cash pile.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
IHT receipts rose by almost an extra £100m in April – and the bills are only going upLatest official figures show families paid £97 million more in inheritance tax than a year ago, as frozen thresholds mean higher bills
-
UK house prices rose 6.4% over the past 12 months – will there be a property market surge?The Land Registry house price index reveals the average property price reached £271,000 in March. Some experts think this could be a ‘new growth phase’
-
'Pension funds shouldn't be pushed into private equity sector'Opinion The private-equity party is over, so don't push pension funds into the sector, says Merryn Somerset Webb.
-
Greg Abel: Warren Buffett’s heir takes the throneGreg Abel is considered a safe pair of hands as he takes centre stage at Berkshire Hathaway. But he arrives after one of the hardest acts to follow in investment history, Warren Buffett. Can he thrive?
-
Who will be the next Warren Buffett?Opinion There won’t be another Warren Buffett. Times have changed, and the opportunities are no longer there, says Matthew Lynn.
-
Will Comstock crash – or soar?Opinion The upside for Comstock, a solar panel-recycling and biomass-refining group, dwarfs the downside, says Dominic Frisby.
-
'As AGMs go digital, firms must offer a new form of scrutiny for shareholders'Opinion Technology has rendered big AGM meet-ups obsolete, but the board still needs to be held to account, says Matthew Lynn
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
-
Two ways to tap into monopoly profits from airportsMost investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?The latest weight-loss treatments could transform public health and the world economy. Should you invest?
